Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget.

Colorectal cancer Crohn’s disease Endoscopy Inflammatory bowel disease Surveillance Ulcerative colitis

Journal

World journal of gastrointestinal endoscopy
ISSN: 1948-5190
Titre abrégé: World J Gastrointest Endosc
Pays: United States
ID NLM: 101532474

Informations de publication

Date de publication:
16 Feb 2022
Historique:
received: 14 06 2021
revised: 02 08 2021
accepted: 22 01 2022
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 24 3 2022
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic immune-mediated inflammatory disease that primarily affects the gastrointestinal tract and is characterized by periods of activity and remission. The inflammatory activity of the disease involving the colon and rectum increases the risk of colorectal cancer (CRC) over the years. Although prevention strategies are evolving, regular surveillance for early detection of neoplasia as a secondary prevention strategy is paramount in the care of IBD patients. In this review article, we discuss the current evidence of the risks of developing CRC and evaluate the best available strategies for screening and surveillance, as well as future opportunities for cancer prevention.

Identifiants

pubmed: 35316980
doi: 10.4253/wjge.v14.i2.85
pmc: PMC8908328
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

85-95

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Rubin DT has received grant support from Takeda; and has served as a consultant for Abbvie, Altrubio, Allergan Inc., Arena Pharmaceuticals, Bellatrix Pharmaceuticals, Boehringer Ingelheim Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, Connect BioPharma, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Pfizer, Prometheus Biosciences, Reistone, Takeda, and Techlab Inc. Quera R has received grant support from Janssen and Nuñez F P has received support for attending meetings from Janssen.

Références

Gut. 2018 Jun;67(6):1087-1094
pubmed: 28698230
J Crohns Colitis. 2021 Jan 13;15(1):24-34
pubmed: 32592468
Gastroenterology. 2006 Jun;130(7):1941-9
pubmed: 16762617
J Crohns Colitis. 2019 Mar 26;13(3):362-373
pubmed: 30321325
Gastroenterology. 2006 Apr;130(4):1030-8
pubmed: 16618396
Clin Gastroenterol Hepatol. 2014 May;12(5):756-64
pubmed: 23920032
Gastrointest Cancer Res. 2011 Mar;4(2):53-61
pubmed: 21673876
Am J Gastroenterol. 2015 Jul;110(7):1014-21
pubmed: 25823770
World J Gastroenterol. 2014 Jul 21;20(27):8783-9
pubmed: 25083052
Am J Gastroenterol. 1991 Jul;86(7):882-5
pubmed: 2058631
Gastroenterology. 2015 Mar;148(3):639-651.e28
pubmed: 25702852
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):789-99
pubmed: 23448792
Therap Adv Gastroenterol. 2020 May 6;13:1756284820920779
pubmed: 32523622
Clin Gastroenterol Hepatol. 2006 Nov;4(11):1309-13
pubmed: 17110299
J Clin Pathol. 2013 Dec;66(12):1005-26
pubmed: 23999270
Frontline Gastroenterol. 2018 Oct;9(4):271-277
pubmed: 30245789
Am J Gastroenterol. 2013 Dec;108(12):1869-76
pubmed: 23978954
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):205-17
pubmed: 25732745
Clin Gastroenterol Hepatol. 2017 Mar;15(3):454-458.e1
pubmed: 27521512
Expert Rev Gastroenterol Hepatol. 2021 Feb;15(2):115-126
pubmed: 33094654
World J Gastroenterol. 2016 Jan 21;22(3):1246-59
pubmed: 26811662
Lancet. 2017 Apr 29;389(10080):1756-1770
pubmed: 27914657
Dig Dis. 2010;28(4-5):629-40
pubmed: 21088415
Arch Oral Biol. 1978;23(3):231-3
pubmed: 278557
Gut. 1992 Jul;33(7):938-41
pubmed: 1644333
Am J Gastroenterol. 2011 Feb;106(2):319-28
pubmed: 21045815
Gastroenterology. 2019 Apr;156(5):1333-1344.e3
pubmed: 30529584
Inflamm Bowel Dis. 2012 Dec;18(12):2240-6
pubmed: 22508402
Gut. 2001 Apr;48(4):526-35
pubmed: 11247898
Gastroenterology. 2001 May;120(6):1356-62
pubmed: 11313305
Gastroenterology. 2001 Apr;120(5):1093-9
pubmed: 11266373
World J Gastroenterol. 2017 Jan 21;23(3):472-477
pubmed: 28210083
Semin Diagn Pathol. 2002 Feb;19(1):31-7
pubmed: 11936264
Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:1-5
pubmed: 12950413
Gut. 2010 May;59(5):666-89
pubmed: 20427401
Gastroenterology. 2021 Apr;160(5):1584-1598
pubmed: 33385426
Hum Pathol. 1998 Feb;29(2):131-6
pubmed: 9490271
J Crohns Colitis. 2017 Jun 1;11(6):649-670
pubmed: 28158501
J Crohns Colitis. 2019 Dec 10;13(12):1485-1491
pubmed: 31175827
Gastrointest Endosc. 2015 May;81(5):1101-21.e1-13
pubmed: 25800660
Gastroenterology. 2012 Aug;143(2):382-9
pubmed: 22609382
Aliment Pharmacol Ther. 2020 Jul;52(1):5-19
pubmed: 32432797
Clin Gastroenterol Hepatol. 2010 Apr;8(4):364-70
pubmed: 19932768
Endoscopy. 2016 Nov;48(11):1029-1045
pubmed: 27711949
Am J Gastroenterol. 2019 Mar;114(3):384-413
pubmed: 30840605
World J Gastroenterol. 2012 Aug 7;18(29):3839-48
pubmed: 22876036
Gastroenterology. 2004 May;126(6):1634-48
pubmed: 15168373
Clin Gastroenterol Hepatol. 2016 May;14(5):704-12.e4
pubmed: 26804384
Am J Gastroenterol. 2013 Mar;108(3):444-9
pubmed: 23295277
Gut. 2019 Mar;68(3):562-572
pubmed: 30580249
Clin Gastroenterol Hepatol. 2012 Jun;10(6):639-45
pubmed: 22289873
Gut. 2004 Dec;53(12):1813-6
pubmed: 15542520
Dig Dis Sci. 1990 Mar;35(3):349-52
pubmed: 2307080
Clin Gastroenterol Hepatol. 2019 Jan;17(1):205-206
pubmed: 29751167
Gastrointest Endosc. 2016 Dec;84(6):1078-1079
pubmed: 27855794
Gut. 2018 Apr;67(4):616-624
pubmed: 28115492
Gastrointest Endosc. 2000 Feb;51(2):123-8
pubmed: 10650251
Gut. 2005 Jan;54(1):91-6
pubmed: 15591511
Gut. 2019 Mar;68(3):414-422
pubmed: 29150489
Hepatology. 2013 Dec;58(6):2045-55
pubmed: 23775876
Gastrointest Endosc. 2002 Jul;56(1):48-54
pubmed: 12085034
Gut. 2008 Sep;57(9):1246-51
pubmed: 18337322
Clin Gastroenterol Hepatol. 2018 Jan;16(1):68-74
pubmed: 28756053
Gastrointest Endosc Clin N Am. 2014 Jul;24(3):447-54
pubmed: 24975535
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1097-104
pubmed: 16611269
Int J Colorectal Dis. 2016 Jan;31(1):9-13
pubmed: 26412249
GE Port J Gastroenterol. 2021 Feb;28(2):97-105
pubmed: 33791396
Gastrointest Endosc. 2019 Feb;89(2):373-379.e2
pubmed: 30339950
Gastrointest Endosc. 2016 Jan;83(1):213-22
pubmed: 26364967
Gut. 2002 Oct;51 Suppl 5:V10-2
pubmed: 12221032
World J Gastroenterol. 2016 May 28;22(20):4794-801
pubmed: 27239106
Semin Cancer Biol. 2020 Aug;64:51-60
pubmed: 31112753
Gastrointest Endosc. 2019 Aug;90(2):186-195.e1
pubmed: 31009609
Int J Colorectal Dis. 2020 Dec;35(12):2301-2307
pubmed: 32812090
Clin Gastroenterol Hepatol. 2016 May;14(5):720-2
pubmed: 26407751
Am J Gastroenterol. 2013 Jul;108(7):1042-56
pubmed: 23649184
Am J Gastroenterol. 2018 Dec;113(12):1801-1809
pubmed: 30353058
Gastroenterol Clin North Am. 2017 Sep;46(3):xiii-xv
pubmed: 28838422
Am J Gastroenterol. 2015 Jul;110(7):1022-34
pubmed: 25823771

Auteurs

Paulina Núñez F (P)

Universidad de los Andes, Digestive Disease Center, Inflammatory Bowel Disease Program, Clinica, Santiago 7620157, RM, Chile.

Rodrigo Quera (R)

Universidad de los Andes, Digestive Disease Center, Inflammatory Bowel Disease Program, Clinica, Santiago 7620157, RM, Chile.

David T Rubin (DT)

Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, IL 60637, United States. drubin@medicine.bsd.uchicago.edu.

Classifications MeSH